Q2 2018
Released Aug 8, 2018, after the close
10-Q filed Aug 8, 2018, 39 days after period end · 0001493152-18-011163
Q2 2018 · 10-Q
Revenue$1.37M$1.37M +59.0% vs Q2 2017+38.7% vs Q1 2018
Net Income-$682.00K-$682.00K N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.10-$0.10 N/M vs Q2 2017N/M vs Q1 2018
Gross Profit$830,000+60.5%
Operating Income-$653,000N/M
Operating Cash Flowderived-$1,343,000N/M
Margins · derived
Gross margin60.8%+0.6 pt vs Q2 2017
Operating margin-47.8%+33.7 pt vs Q2 2017
Net margin-49.9%+41.6 pt vs Q2 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $1.37M | $859.00K | $509.00K | $567.00K |
| Net Income | -$682.00K | -$786.00K | -$835.00K | -$1.82M |
| EPS Diluted | -$0.10 | -$0.01 | -$0.02 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR